ROCK inhibition prevents tau hyperphosphorylation and p25/CDK5 increase after global cerebral ischemia

Behavioral Neuroscience

Volumn 125, Issue 3, 2011, Pages 465-472

  Castro Alvarez, John Fredy ^a   Gutierrez Vargas, Johanna ^a   Darnaudéry, Muriel ^b   Cardona Gómez, Gloria Patricia ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

CDK 5; Global cerebral ischemia; Neuroprotection; ROCK inhibitor; Spatial learning and memory; Tau hyperphosphorylation

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CYCLIN DEPENDENT KINASE 5; PROTEIN P25; RHO KINASE; TAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DOWN REGULATION; HIPPOCAMPUS; LEARNING; LONG TERM MEMORY; MALE; NERVE DEGENERATION; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; REFERENCE MEMORY; SPATIAL MEMORY; TAUOPATHY;

AMIDES; ANIMALS; BRAIN ISCHEMIA; CYCLIN-DEPENDENT KINASE 5; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; ENZYME INHIBITORS; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; MEMORY DISORDERS; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; PYRIDINES; RATS; RATS, WISTAR; RHO-ASSOCIATED KINASES; SPATIAL BEHAVIOR; TAU PROTEINS;

EID: 79958725737     PISSN: 07357044     EISSN: 19390084     Source Type: Journal    
DOI: 10.1037/a0023167     Document Type: Article

References (60)

1. Ahnert-Hilger G., Holtje M., Grosse G., Pickert G., Mucke C., Nixdorf-Bergweiler B., Just I. Differential effects of Rho GTPases on axonal and dendritic development in hippocampal neurones. Journal of Neurochemistry 2004, 90:9-18.
2. Alexander K., Yang H.S., Hinds P.W. Cellular senescence requires CDK5 repression of Rac1 activity. Molecular Cell Biology 2004, 24:2808-2819.
3. Amano M., Kaneko T., Maeda A., Nakayama M., Ito M., Yamauchi T., Kaibuchi K. Identification of Tau and MAP2 as novel substrates of Rho-kinase and myosin phosphatase. Journal of Neurochemistry 2003, 87:780-790.
4. Avila J., Lucas J.J., Perez M., Hernandez F. Role of tau protein in both physiological and pathological conditions. Physiological Reviews 2004, 84:361-384.
5. Brabeck C., Mittelbronn M., Bekure K., Meyermann R., Schluesener H.J., Schwab J.M. Effect of focal cerebral infarctions on lesional RhoA and RhoB expression. Archives of Neurology 2003, 60:1245-1249.
6. Cruz J.C., Tseng H.C., Goldman J.A., Shih H., Tsai L.H. Aberrant Cdk5 activation by pp. 25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 2003, 40:471-483.
7. Darnaudéry M., Perez-Martin M., Del Favero F., Gomez-Roldan C., Garcia-Segura L.M., Maccari S. Early motherhood in rats is associated with a modification of hippocampal function. Psychoneuroendocrinology 2007, 32:803-812.
8. Dash P.K., Orsi S.A., Moody M., Moore A.N. A role for hippocampal Rho-ROCK pathway in long-term spatial memory. Biochemical and Biophysical Research Communications 2004, 322:893-898.
9. Diana G., Valentini G., Travaglione S., Falzano L., Pieri M., Zona C., Fiorentini C. Enhancement of learning and memory after activation of cerebral Rho GTPases. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:636-641.
10. Flaherty D.B., Soria J.P., Tomasiewicz H.G., Wood J.G. Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants. Journal of Neuroscience Research 2000, 62:463-472.
11. Fu W.Y., Chen Y., Sahin M., Zhao X.S., Shi L., Bikoff J.B., Ip N.Y. Cdk5 regulates EphA4-mediated dendritic spine retraction through an ephexin1-dependent mechanism. Nature Neuroscience 2007, 10:67-76.
12. Gutiérrez-Vargas J., Castro-Álvarez J.F., Velásquez-Carvajal D., Montañez-Velásquez M.N., Céspedes-Rubio A., Cardona-Gómez G.P. Changes in the activity of Rac1 correlates with the neuronal pathology and the spatial memory long-term recovery after global cerebral ischemia. Neurochemistry International 2010, 57:762-773.
13. Hahn C.M., Kleinholz H., Koester M.P., Grieser S., Thelen K., Pollerberg G.E. Role of cyclin-dependent kinase 5 and its activator P35 in local axon and growth cone stabilization. Neuroscience 2005, 134:449-465.
14. Hirata A., Inatani M., Inomata Y., Yonemura N., Kawaji T., Honjo M., Tanihara H. Y-27632, a Rho-associated protein kinase inhibitor, attenuates neuronal cell death after transient retinal ischemia. Graefes Archive For Clinical and Experimental Ophthalmology 2008, 246:51-59.
15. Huang L., He Z., Guo L., Wang H. Improvement of cognitive deficit and neuronal damage in rats with chronic cerebral ischemia via relative long-term inhibition of rho-kinase. Cellular and Molecular Neurobiology 2008, 28:757-768.
16. Huang L., Li Q., Li H., He Z., Cheng Z., Chen J., Guo L. Inhibition of intracellular Ca2+ release by a Rho-kinase inhibitor for the treatment of ischemic damage in primary cultured rat hippocampal neurons. European Journal of Pharmacology 2009, 602:238-244.
17. Johnson D.I., Pringle J.R. Molecular characterization of CDC42, a Saccharomyces cerevisiae gene involved in the development of cell polarity. Journal of Cell Biology 1990, 111:143-152.
18. Kesavapany S., Amin N., Zheng Y.L., Nijhara R., Jaffe H., Sihag R., Pant H.C. 35/cyclin-dependent kinase 5 phosphorylation of ras guanine nucleotide releasing factor 2 (RasGRF2) mediates Rac-dependent Extracellular Signal-regulated kinase 1/2 activity, altering RasGRF2 and microtubule-associated protein 1b distribution in neurons. Journal of Neuroscience 2004, 24:4421-4431.
19. Kranenburg O., Poland M., van Horck F.P., Drechsel D., Hall A., Moolenaar W.H. Activation of RhoA by lysophosphatidic acid and Galpha12/13 subunits in neuronal cells: Induction of neurite retraction. Molekuliarnaia Biologiia Cell 1999, 10:1851-1857.
20. Lamprecht R., Farb C.R., LeDoux J.E. Fear memory formation involves pp. 190 RhoGAP and ROCK proteins through a GRB2-mediated complex. Neuron 2002, 36:727-738.
21. Lamprecht R., LeDoux J. Structural plasticity and memory. Nature Reviews Neuroscience 2004, 5:45-54.
22. Li Q., Huang X.J., He W., Ding J., Jia J.T., Fu G., Guo L.J. Neuroprotective potential of fasudil mesylate in brain ischemia-reperfusion injury of rats. Cellular and Molecular Neurobiology 2009, 29:169-180.
23. Lilja L., Yang S.N., Webb D.L., Juntti-Berggren L., Berggren P.O., Bark C. Cyclin-dependent kinase 5 promotes insulin exocytosis. Journal of Biological Chemistry 2001, 276:34199-34205.
24. Maekawa M., Ishizaki T., Boku S., Watanabe N., Fujita A., Iwamatsu A., Narumiya S. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 1999, 285:895-898.
25. Markesbery W.R., Schmitt F.A., Kryscio R.J., Davis D.G., Smith C.D., Wekstein D.R. Neuropathologic substrate of mild cognitive impairment. Archives of Neurology 2006, 63:38-46.
26. Marosi M., Rakos G., Robotka H., Nemeth H., Sas K., Kis Z., Toldi J. Hippocampal (CA1) activities in Wistar rats from different vendors. Fundamental differences in acute ischemia. Journal of Neuroscience Methods 2006, 156:231-235.
27. Mattson M.P. Calcium and neurodegeneration. Aging Cell 2007, 6:337-350.
28. Ming X.F., Viswambharan H., Barandier C., Ruffieux J., Kaibuchi K., Rusconi S., Yang Z. Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Molecular Cell Biology 2002, 22:8467-8477.
29. Morris R.G., Garrud P., Rawlins J.N., O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 1982, 297:681-683.
30. Nikolic M., Chou M.M., Lu W., Mayer B.J., Tsai L.H. The pp. 35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity. Nature 1998, 395:194-198.
31. Nikolic M., Dudek H., Kwon Y.T., Ramos Y.F., Tsai L.H. The cdk5/pp. 35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes and Development 1996, 10:816-825.
32. Noma K., Oyama N., Liao J.K. Physiological role of ROCKs in the cardiovascular system. American Journal of Physiology Cell Physiology 2006, 290:C661-668.
33. Ohashi K., Nagata K., Maekawa M., Ishizaki T., Narumiya S., Mizuno K. Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop. Journal of Biological Chemistry 2000, 275:3577-3582.
34. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, San Diego, CA. 4th ed.
35. Plattner F., Angelo M., Giese K.P. The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation. Journal of Biological Chemistry 2006, 281:25457-25465.
36. Ramakers G.J. Rho proteins, mental retardation and the cellular basis of cognition. Trends in Neurosciences 2002, 25:191-199.
37. Rashid T., Banerjee M., Nikolic M. Phosphorylation of Pak1 by the pp. 35/Cdk5 kinase affects neuronal morphology. Journal of Biological Chemistry 2001, 276:49043-49052.
38. Ridley A.J., Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992, 70:389-399.
39. Ridley A.J., Paterson H.F., Johnston C.L., Diekmann D., Hall A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 1992, 70:401-410.
40. Rikitake Y., Kim H.H., Huang Z., Seto M., Yano K., Asano T., Liao J.K. Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke 2005, 36:2251-2257.
41. Ruchhoeft M.L., Ohnuma S., McNeill L., Holt C.E., Harris W.A. The neuronal architecture of Xenopus retinal ganglion cells is sculpted by rho-family GTPases in vivo. Journal of Neuroscience 1999, 19:8454-8463.
42. Salinska E., Danysz W., Lazarewicz J.W. The role of excitotoxicity in neurodegeneration. Folia Neuropathologica 2005, 43:322-339.
43. Satoh S., Ikegaki I., Suzuki Y., Asano T., Shibuya M., Hidaka H. Neuroprotective properties of a protein kinase inhibitor against ischaemia-induced neuronal damage in rats and gerbils. British Journal of Pharmacology 1996, 118:1592-1596.
44. Satoh S., Toshima Y., Hitomi A., Ikegaki I., Seto M., Asano T. Wide therapeutic time window for Rho-kinase inhibition therapy in ischemic brain damage in a rat cerebral thrombosis model. Brain Research 2008, 1193:102-108.
45. Satoh S., Utsunomiya T., Tsurui K., Kobayashi T., Ikegaki I., Sasaki Y., Asano T. Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage. Life Sciences 2001, 69:1441-1453.
46. Schindowski K., Bretteville A., Leroy K., Begard S., Brion J.P., Hamdane M., Buee L. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. American Journal of Pathology 2006, 169:599-616.
47. Schmued L.C., Albertson C., Slikker W. Fluoro-Jade: A novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Research 1997, 751:37-46.
48. Semenova M.M., Maki-Hokkonen A.M., Cao J., Komarovski V., Forsberg K.M., Koistinaho M., Courtney M.J. Rho mediates calcium-dependent activation of pp. 38alpha and subsequent excitotoxic cell death. Nature Neuroscience 2007, 10:436-443.
49. Shibuya M., Hirai S., Seto M., Satoh S., Ohtomo E. Effects of fasudil in acute ischemic stroke: Results of a prospective placebo-controlled double-blind trial. Journal of Neurology Science 2005, 238:31-39.
50. Shin H.K., Salomone S., Potts E.M., Lee S.W., Millican E., Noma K., Ayata C. Rho-kinase inhibition acutely augments blood flow in focal cerebral ischemia via endothelial mechanisms. Journal of Cerebral Blood Flow and Metabolism 2007, 27:998-1009.
51. Tashiro A., Minden A., Yuste R. Regulation of dendritic spine morphology by the rho family of small GTPases: Antagonistic roles of Rac and Rho. Cerebral Cortex 2000, 10:927-938.
52. Tashiro A., Yuste R. Regulation of dendritic spine motility and stability by Rac1 and Rho kinase: Evidence for two forms of spine motility. Molecular Cell Neuroscience 2004, 26:429-440.
53. Toshima Y., Satoh S., Ikegaki I., Asano T. A new model of cerebral microthrombosis in rats and the neuroprotective effect of a Rho-kinase inhibitor. Stroke 2000, 31:2245-2250.
54. Totsukawa G., Yamakita Y., Yamashiro S., Hartshorne D.J., Sasaki Y., Matsumura F. Distinct roles of ROCK (Rho-kinase) and MLCK in spatial regulation of MLC phosphorylation for assembly of stress fibers and focal adhesions in 3T3 fibroblasts. Journal of Cell Biology 2000, 150:797-806.
55. Wen Y., Yang S., Liu R., Brun-Zinkernagel A.M., Koulen P., Simpkins J.W. Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer's disease-like tauopathy in female rats. Journal of Biological Chemistry 2004, 279:22684-22692.
56. Wen Y., Yang S., Liu R., Simpkins J.W. Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein. Brain Research 2004, 1022:30-38.
57. Xin X., Wang Y., Ma X.M., Rompolas P., Keutmann H.T., Mains R.E., Eipper B.A. Regulation of Kalirin by Cdk5. Journal of Cell Science 2008, 121:2601-2611.
58. Yamashita K., Kotani Y., Nakajima Y., Shimazawa M., Yoshimura S., Nakashima S., Hara H. Fasudil, a Rho kinase (ROCK) inhibitor, protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons. Brain Research 2007, 1154:215-224.
59. Yano K., Kawasaki K., Hattori T., Tawara S., Toshima Y., Ikegaki I., Seto M. Demonstration of elevation and localization of Rho-kinase activity in the brain of a rat model of cerebral infarction. European Journal of Pharmacology 2008, 594:77-83.
60. Zhang Z., Ottens A.K., Larner S.F., Kobeissy F.H., Williams M.L., Hayes R.L., Wang K.K. Direct Rho-associated kinase inhibiton induces cofilin dephosphorylation and neurite outgrowth in PC-12 cells. Cellular and Molecular Biology Letters 2006, 11:12-29.